48
Participants
Start Date
April 9, 2024
Primary Completion Date
October 2, 2024
Study Completion Date
October 2, 2024
AMBITION trial control
Induction therapy for control group participants followed the 2018 WHO cryptococcal guidelines with 7 days of 5-FC 100mg/kg/day and 7 days of IV Amphotericin deoxycholate followed by 1200mg fluconazole/day for 7 days.
Flucytosine
Participants in the trial will receive 60mg/kg/day of 5-FC in 3 divided doses for 10 days. Single-dose liposomal amphotericin (10mg/kg) is preferred, if available. Amphotericin B 0.7-1.0 mg/kg/day may be used if needed.
Mbarara University of Science and Technology, Mbarara
Infectious Disease Institute, Mulago Hospital Complex, Kampala
Collaborators (1)
Infectious Diseases Institute, Makerere University
UNKNOWN
Mbarara University of Science and Technology
OTHER
Meningitis Foundation
UNKNOWN
University of Minnesota
OTHER